Related Experiment Video
Updated: Jun 21, 2026
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Cardiovascular biomarkers in the ICU
Markus Noveanu1, Alexandre Mebazaa, Christian Mueller
1Department of Internal Medicine, University Hospital Basel, Basel, Switzerland. noveanum@uhbs.ch
Current Opinion in Critical Care
|July 17, 2009
Summary
Natriuretic peptides offer excellent prognosis in ICU patients, but their diagnostic use remains unclear. Cardiac troponins (cTn) screening identifies more myocardial infarctions and provides prognostic insights in critically ill individuals.
Area of Science:
- Critical care medicine
- Cardiology
- Biomarker research
Background:
- Natriuretic peptides and cardiac troponins (cTn) are vital biomarkers in emergency and critical care settings.
- Interpretation of these biomarkers can be challenging in critically ill patients due to factors like organ dysfunction.
Purpose of the Study:
- To review recent literature on the application of natriuretic peptides and cTn in critically ill patients.
- To evaluate the diagnostic and prognostic utility of these biomarkers in the intensive care unit (ICU).
Main Methods:
- Review of recently published articles focusing on natriuretic peptides and cTn in critically ill populations.
- Analysis of studies investigating biomarker utility in differentiating types of pulmonary edema and assessing patient outcomes.
Main Results:
- Natriuretic peptides demonstrate strong prognostic value in general and non-cardiac ICU patients, with specific insights into elevated levels during septic shock.
- B-type natriuretic peptide shows potential in distinguishing cardiogenic from non-cardiogenic pulmonary edema.
- Systematic cTn screening in ICUs identifies additional myocardial infarctions and offers prognostic information.
Conclusions:
- The prognostic capability of natriuretic peptides in ICU patients is well-established.
- The diagnostic accuracy of natriuretic peptides in the ICU requires further investigation.
- Routine cTn screening enhances the detection of myocardial infarction and improves prognostic assessment in critically ill patients.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:29Endocarditis IV: Nursing Management
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
01:26Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...